Idiopathic intermediate uveitis | Presumed sarcoid intermediate uveitis | Normal controls | |
---|---|---|---|
CCR4 | 31.3 (26.0–37.1) | 25.6 (20.8–27.8) | 31.5 (27.2–33.0) |
CCR5 | 5.5 (3.3–9.2) | 6.0 (3.3–8.1) | 6.0 (21.5–9.6) |
CXCR3 | 21.0 (12.0–35.0) | 13.7 (8.9–23.0) | 21.1 (10.2–36.5) |
CD69 | 52.5 (46.7–58.2)** | 53.8 (52.2–56.9)* | 38.4 (29.8–47.8) |
IL-10 unstimulated | 0.2 (0.2–0.6) | 0.4 (0.3–0.5) | 0.3 (1.2–0.7) |
IL-10 activated | 0.7 (0.3–2.9) | 1.2 (1.0–1.6) | 0.8 (0.6–1.6) |
TNFα unstimulated | 4.3 (2.9–6.1) | 4.3 (4.1–6.8) | 4.4 (1.2–9.1) |
TNFα activated | 70.7 (61.4–76.1)* | 71.1 (68.9–74.3)* | 56.5 (52.8–70.2) |
IFNγ unstimulated | 0.4 (0.2–0.6) | 0.6 (0.5–0.6) | 0.3 (0.2–0.4) |
IFNγ activated | 6.5 (4.9–10.4) | 8.4 (8.3–14.5) | 7.3 (5.5–12.1) |